MoonLake Immunotherapeutics - COMMON STOCK (MLTX)

CUSIP: 61559X104

Q1 2023 13F Holders as of 31 Mar 2023

Holder snapshot 6 signals
Share change
+1,669,713
SEC-reported price per share
$21.39
Indexed holders
43
Value change
+$59,244,738
Number of buys
31
Number of sells
17
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
80,766,491

Security key

61559X104

Report period

Q1 2023

Indexed institutions

43

Top holders

10

Ownership snapshot

Top reported holders of MLTX - MoonLake Immunotherapeutics - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
BVF INC/IL
Disclosed value leader
BVF INC/IL
Comparable rows
0/15
Latest evidence
31 Dec 2022
13F 3/4/5 Highest disclosed value: $228,388,482 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

BVF INC/IL has the largest disclosed position value at $228.39M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens BVF INC/IL's linked filing trail.
Disclosed position value Top 5
BVF INC/IL $228.39M
Helix Holdings LLC $192.57M
Cormorant Asset Management, LP $63.68M
CITADEL ADVISORS LLC $30.3M
TCG Crossover Management, LLC $10.5M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
BVF INC/IL
13F
Company
13F
—
denominator unverified
$228,388,482
21,751,284 shares
— 31 Dec 2022
Helix Holdings LLC
3/4/5
Former 10% Holder
—
denominator unverified
$192,569,820
3,215,000 shares
— 05 Apr 2022
Cormorant Asset Management, LP
13F
Company
13F
—
denominator unverified
$63,683,000
6,065,001 shares
— 31 Dec 2022
CITADEL ADVISORS LLC
13F
Company
13F
—
denominator unverified
$30,303,967
2,886,092 shares
— 31 Dec 2022
TCG Crossover Management, LLC
13F
Company
13F
—
denominator unverified
$10,500,000
1,000,000 shares
— 31 Dec 2022
Polar Capital Holdings Plc
13F
Company
13F
—
denominator unverified
$9,201,959
876,377 shares
— 31 Dec 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2023

Investor-level positions for this CUSIP, loaded as an interactive table.

Indexed institutions
43
Shares
39,419,149
Indexed holders
43
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Reported share positions only; options and principal amounts are excluded. Missing manager disclosures are unavailable, not zero. A missing position becomes zero only when complete coverage is verified for both snapshots. Counts describe the indexed universe; the comparison may cover a smaller set.

Compare Q1 2023 vs Q4 2022 Across Filers

Q4 2022 indexed holders
32
Q1 2023 indexed holders
43
Indexed holder difference
11
Investor Q4 2022 Shares Q1 2023 Shares Share Diff Share Chg % Q4 2022 value Q1 2023 value Value change Value Chg %

Trend: the last eight indexed quarters, including the selected comparison periods.

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .